Overview

A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

Status:
RECRUITING
Trial end date:
2027-12-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and effectiveness of mavacamten in adults with obstructive hypertrophic cardiomyopathy in India.
Phase:
PHASE4
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
MYK-461